Evidence map›Paper›PMID 25329529›Full record

ArticlePloS one2014

Systematic analysis of blood cell transcriptome in end-stage chronic respiratory diseases.

Julie Chesné, Richard Danger, Karine Botturi, Martine Reynaud-Gaubert, Sacha Mussot, Marc Stern, Isabelle Danner-Boucher, Jean-François Mornex, Christophe Pison, Claire Dromer and 10 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Meta-analysis of blood genome-wide expression profiling studies in pulmonary arterial hypertension.American journal of physiology. Lung cellular and molecular physiology · 2020
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. The Role of the Transcriptional Coactivator BOB.1/OBF.1 in Adaptive Immunity.Advances in experimental medicine and biology · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis.American journal of respiratory and critical care medicine · 2020
    Article
  15. Can intestinal microbiota and circulating microbial products contribute to pulmonary arterial hypertension?American journal of physiology. Heart and circulatory physiology · 2019
    Review
  16. Article
  17. Disconnect between Fibrotic Response and Right Ventricular Dysfunction.American journal of respiratory and critical care medicine · 2019
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 12 institutions in 1 country.

Julie ChesnéUMR_S 1087 CNRS UMR_6291, l'Institut du Thorax, Université de Nantes, CHU de Nantes, Centre National de Référence Mucoviscidose Nantes-Roscoff, Nantes, France; Université de Nantes, Nantes, France.
Richard DangerUniversité de Nantes, Nantes, France; Institut National de la Santé et de la Recherche Médicale INSERM U1064, and Institut de Transplantation Urologie Néphrologie du Centre Hospitalier Universitaire Hôtel Dieu, Nantes, France.
Karine BotturiUMR_S 1087 CNRS UMR_6291, l'Institut du Thorax, Université de Nantes, CHU de Nantes, Centre National de Référence Mucoviscidose Nantes-Roscoff, Nantes, France; Université de Nantes, Nantes, France.
Martine Reynaud-GaubertCHU de Marseille, Aix Marseille Université, Marseille, France.
Sacha MussotCentre Chirurgical Marie Lannelongue, Service de Chirurgie Thoracique, Vasculaire et Transplantation Cardiopulmonaire, Le Plessis Robinson, France.
Marc SternHôpital Foch, Suresnes, France.
Isabelle Danner-BoucherUMR_S 1087 CNRS UMR_6291, l'Institut du Thorax, Université de Nantes, CHU de Nantes, Centre National de Référence Mucoviscidose Nantes-Roscoff, Nantes, France.
Jean-François MornexUniversité de Lyon, Lyon, France; Université de Lyon 1, Lyon, France; INRA, UMR_S 754, Lyon, France; Hospices Civils de Lyon, Lyon, France.
Christophe PisonClinique Universitaire Pneumologie, CHU de Grenoble, Grenoble, France; Université Joseph Fourier, Grenoble, France; Inserm U1055, Grenoble, France; European Institute of Systems Biology and Medicine, Lyon, France.
Claire DromerCHU de Bordeaux, Bordeaux, France.
Romain KesslerCHU de Strasbourg, Strasbourg, France.
Marcel DahanCHU de Toulouse, Toulouse, France.
Olivier BrugièreHôpital Bichat, Service de Pneumologie B et Transplantation Pulmonaire, Paris, France.
Jérôme Le PavecCentre Chirurgical Marie Lannelongue, Service de Chirurgie Thoracique, Vasculaire et Transplantation Cardiopulmonaire, Le Plessis Robinson, France.
Frédéric PerrosUniversité Paris-Sud, Le Kremlin-Bicêtre, France; AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; INSERM U999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France.
Marc HumbertUniversité Paris-Sud, Le Kremlin-Bicêtre, France; AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; INSERM U999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France.
Carine GomezCHU de Marseille, Aix Marseille Université, Marseille, France.
Sophie BrouardUniversité de Nantes, Nantes, France; Institut National de la Santé et de la Recherche Médicale INSERM U1064, and Institut de Transplantation Urologie Néphrologie du Centre Hospitalier Universitaire Hôtel Dieu, Nantes, France.
Antoine MagnanUMR_S 1087 CNRS UMR_6291, l'Institut du Thorax, Université de Nantes, CHU de Nantes, Centre National de Référence Mucoviscidose Nantes-Roscoff, Nantes, France; Université de Nantes, Nantes, France.
COLT Consortium
Centre Chirurgical Marie Lannelongue · FRAix-Marseille Université · FRCentre Hospitalier Universitaire de Nantes · FRCentre National de la Recherche Scientifique · FRNantes Université · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Toulouse · FRHôpital Bichat-Claude-Bernard · FRHôpital Foch · FRInserm · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEnd-stage chronic respiratory diseases (CRD) have systemic consequences, such as weight loss and susceptibility to infection. However the mechanisms of such dysfunctions are as yet poorly explained. We hypothesized that the genes putatively involved in these mechanisms would emerge from a systematic analysis of blood mRNA profiles from pre-transplant patients with cystic fibrosis (CF), pulmonary hypertension (PAH), and chronic obstructive pulmonary disease (COPD).

methodsWhole blood was first collected from 13 patients with PAH, 23 patients with CF, and 28 Healthy Controls (HC). Microarray results were validated by quantitative PCR on a second and independent group (7PAH, 9CF, and 11HC). Twelve pre-transplant COPD patients were added to validate the common signature shared by patients with CRD for all causes. To further clarify a role for hypoxia in the candidate gene dysregulation, peripheral blood mononuclear cells from HC were analysed for their mRNA profile under hypoxia.

resultsUnsupervised hierarchical clustering allowed the identification of 3 gene signatures related to CRD. One was common to CF and PAH, another specific to CF, and the final one was specific to PAH. With the common signature, we validated T-Cell Factor 7 (TCF-7) and Interleukin 7 Receptor (IL-7R), two genes related to T lymphocyte activation, as being under-expressed. We showed a strong impact of the hypoxia on modulation of TCF-7 and IL-7R expression in PBMCs from HC under hypoxia or PBMCs from CRD. In addition, we identified and validated genes upregulated in PAH or CF, including Lectin Galactoside-binding Soluble 3 and Toll Like Receptor 4, respectively.

conclusionsSystematic analysis of blood cell transcriptome in CRD patients identified common and specific signatures relevant to the systemic pathologies. TCF-7 and IL-7R were downregulated whatever the cause of CRD and this could play a role in the higher susceptibility to infection of these patients.

Indexed as

Gene Expression ProfilingAdultBlood CellsCase-Control StudiesCell HypoxiaCluster AnalysisCystic FibrosisGene OntologyHumansHypertension, PulmonaryLung DiseasesMiddle AgedOligonucleotide Array Sequence AnalysisPulmonary Disease, Chronic ObstructiveReceptors, Interleukin-1RNA, MessengerReceptors, Interleukin-1RNA, MessengerT Cell Transcription Factor 1TCF7 protein, human

Identifiers

PMID25329529
PMCPMC4203719
OpenAlexW2155524404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.